Contributor:

360º Giant Retinal Tear

Ross Lakhanpal, MD

Employing New Surgical Techniques

Geeta A. Lalwani, MD, Vaidehi Dedania, MD

Talking to Patients About Treatment Risks

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Why Retina Specialists Are Growing More Comfortable With Early Treatment

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Delayed Complement Inhibition Therapy per Patient Request

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Multimodal Imaging for Biomarker Detection in GA Patients

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Complement Inhibition Therapy in a Monocular Patient With a New CNV

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

GA in the Presence of Dense Cataract, Followed by CNV Development

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

GA Patient Who Becomes Monocular Over Time Due to the Wet AMD

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

OCT of the Peripheral Retina

Geeta A. Lalwani, MD, Netan Choudhry, MD, FRCS(C)

Treat the Patient, Not the Test

Geeta A. Lalwani, MD, Jay S. Duker, MD

Tips for Successful Retinal Implant Surgery

Aleksandra Rachitskaya, MD, Geeta A. Lalwani, MD

What’s Next: VBS 2025 (Part 1)

Geeta A. Lalwani, MD, and R.V. Paul Chan, MD, MSC, MBA, FACS

What’s Next: VBS 2025 (Part 2)

Geeta A. Lalwani, MD, and R.V. Paul Chan, MD, MSC, MBA, FACS

A First Time for Everything: Gene Therapy Pearls

Audina M. Berrocal MD, Geeta A. Lalwani, MD